ProfileGDS4718 / 224566_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 97% 92% 97% 99% 90% 97% 95% 99% 98% 95% 98% 97% 90% 88% 98% 93% 92% 96% 94% 96% 97% 98% 98% 98% 92% 98% 98% 99% 88% 93% 89% 98% 98% 99% 99% 97% 98% 98% 95% 96% 97% 97% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.141897
GSM549102patient 115, normal, homogenized [OPG study]10.793397
GSM549104patient 119, normal, homogenized [OPG study]9.6607792
GSM549108patient 138, normal, homogenized [OPG study]10.773397
GSM549119patient 077, normal, homogenized [OPG study]12.047599
GSM549133patient 032, cancer, homogenized [OPG study]9.2541490
GSM549139patient 042, cancer, homogenized [OPG study]10.770297
GSM549099patient 107, normal, homogenized [OPG study]10.111895
GSM549109patient 139, normal, homogenized [OPG study]12.023399
GSM549110patient 046, normal, homogenized [OPG study]11.684798
GSM549114patient 063, normal, homogenized [OPG study]10.577695
GSM549122patient 082, normal, homogenized [OPG study]11.507198
GSM549134patient 033, cancer, homogenized [OPG study]11.087297
GSM549136patient 036, cancer, homogenized [OPG study]9.2115590
GSM549140patient 044, cancer, homogenized [OPG study]8.9939588
GSM549111patient 047, normal, homogenized [OPG study]11.763498
GSM549113patient 057, normal, homogenized [OPG study]10.049193
GSM549132patient 031, cancer, homogenized [OPG study]9.484992
GSM549137patient 038, cancer, homogenized [OPG study]10.355196
GSM549142patient 047, cancer, homogenized [OPG study]9.3988994
GSM549100patient 110, normal, homogenized [OPG study]10.717596
GSM549107patient 135, normal, homogenized [OPG study]10.973597
GSM549115patient 068, normal, homogenized [OPG study]11.478898
GSM549116patient 072, normal, homogenized [OPG study]11.932698
GSM549120patient 078, normal, homogenized [OPG study]11.669898
GSM549131patient 030, cancer, homogenized [OPG study]9.6310992
GSM549118patient 074, normal, homogenized [OPG study]11.736398
GSM549129patient 027, cancer, homogenized [OPG study]11.279998
GSM549123patient 088, normal, homogenized [OPG study]12.364599
GSM549124patient 006, cancer, homogenized [OPG study]8.7388188
GSM549126patient 015, cancer, homogenized [OPG study]9.5798793
GSM549128patient 025, cancer, homogenized [OPG study]9.0497189
GSM549103patient 117, normal, homogenized [OPG study]11.702498
GSM549117patient 073, normal, homogenized [OPG study]11.846998
GSM549138patient 041, cancer, homogenized [OPG study]12.765199
GSM549141patient 045, cancer, homogenized [OPG study]11.772799
GSM549130patient 028, cancer, homogenized [OPG study]10.677697
GSM549101patient 111, normal, homogenized [OPG study]11.595698
GSM549105patient 128, normal, homogenized [OPG study]11.424798
GSM549106patient 134, normal, homogenized [OPG study]10.459295
GSM549112patient 048, normal, homogenized [OPG study]10.542296
GSM549125patient 011, cancer, homogenized [OPG study]10.642297
GSM549127patient 024, cancer, homogenized [OPG study]10.968697
GSM549135patient 035, cancer, homogenized [OPG study]10.137595